| The role and mechanism of epithelial-to-mesenchymal transition in prostate cancer progression UG Lo, CF Lee, MS Lee, JT Hsieh International journal of molecular sciences 18 (10), 2079, 2017 | 115 | 2017 |
| Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma CY Chen, YS Lin, CL Chen, PZ Chao, JF Chiou, CC Kuo, FP Lee, YF Lin, ... Oncotarget 6 (29), 26946, 2015 | 48 | 2015 |
| SPARC is a key mediator of TGF‐β‐induced renal cancer metastasis JM Bao, Q Dang, CJ Lin, UG Lo, B Feldkoren, A Dang, E Hernandez, F Li, ... Journal of cellular physiology 236 (3), 1926-1938, 2021 | 39 | 2021 |
| Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis CJ Ko, TW Hsu, SR Wu, SW Lan, TF Hsiao, HY Lin, HH Lin, HF Tu, ... Oncogene 39 (37), 5950-5963, 2020 | 39 | 2020 |
| Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase CF Lee, A Dang, E Hernandez, RC Pong, B Chen, R Sonavane, G Raj, ... Oncogene 38 (28), 5580-5598, 2019 | 39 | 2019 |
| Afatinib exerts immunomodulatory effects by targeting the pyrimidine biosynthesis enzyme CAD HF Tu, CJ Ko, CT Lee, CF Lee, SW Lan, HH Lin, HY Lin, CC Ku, DY Lee, ... Cancer Research 81 (12), 3270-3282, 2021 | 17 | 2021 |
| Huntingtin-associated protein 1 interacts with breakpoint cluster region protein to regulate neuronal differentiation PT Huang, CH Chen, IU Hsu, SA Salim, SH Kao, CW Cheng, CH Lai, ... PloS one 10 (2), e0116372, 2015 | 14 | 2015 |
| The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC CF Lee, YA Chen, E Hernandez, RC Pong, S Ma, M Hofstad, P Kapur, ... Clinical and Translational Medicine 12 (2), e695, 2022 | 13 | 2022 |
| Nuclear morphology predicts cell survival to cisplatin chemotherapy CJ Kim, ALK Gonye, K Truskowski, CF Lee, YK Cho, RH Austin, KJ Pienta, ... Neoplasia 42, 100906, 2023 | 11 | 2023 |
| Split-hand index for amyotrophic lateral sclerosis diagnosis: A frequentist and Bayesian meta-analysis WZ Lu, HA Lin, SK Hou, CF Lee, CH Bai, SF Lin Clinical Neurophysiology 143, 56-66, 2022 | 7 | 2022 |
| Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis HY Lin, CJ Ko, TY Lo, SR Wu, SW Lan, CA Huang, YC Lin, HH Lin, HF Tu, ... Oncogene 41 (20), 2833-2845, 2022 | 6 | 2022 |
| Gain-of-“endocytic’function in mutant p53 cancer cells AM Lakoduk, CF Lee, PH Chen The International Journal of Biochemistry & Cell Biology 131, 105905, 2021 | 4 | 2021 |
| Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study Journal of Translational Medicine 21 (714), 2023 | 3 | 2023 |
| Novel urinary tract obstruction marker discovery by multi-marker profiling of urinary extracellular vesicles derived from a rat UTO model NM Haney, CJ Kim, MD Kuczler, CF Lee, K Lombardo, TJ Bivalacqua, ... American journal of clinical and experimental urology 11 (2), 136, 2023 | 1 | 2023 |
| Predicting clinically significant prostate cancer using urine metabolomics via liquid chromatography mass spectrometry CH Chen, HP Huang, KH Chang, MS Lee, CF Lee, CY Lin, YC Lin, ... The World Journal of Men's Health 42, 2024 | | 2024 |
| A non-canonical CDK9 complex mediates endocycling in polyaneuploid cancer cell (PACC) state C Lee, M Loycano, L LOFTUS, L Kostecka, M Li, S Amend, K Pienta Cancer Research 83 (7_Supplement), 5988-5988, 2023 | | 2023 |
| Impact of the cancer endocycle on cell survival after therapy R Austin, K Pienta, CJ Kim, A Gonye, K Truskowski, CF Lee, YK Cho, ... APS March Meeting Abstracts 2023, M52. 002, 2023 | | 2023 |
| Impact of the cancer endocycle on cell survival after therapy CJ Kim, ALK Gonye, K Truskowski, CF Lee, YK Cho, KJ Pienta, RH Austin, ... bioRxiv, 2022.09. 19.508515, 2022 | | 2022 |
